Leap Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.116; its P/E ratio is -0.63; Leap Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -15.33M	$ -14.81M	$ -43.03M	$ -10.28M	$ -15.08M
EBITDA	$ -15.23M	$ -14.70M	$ -42.93M	$ -10.17M	$ -15.08M
Net Income Common Stockholders	$ -13.70M	$ -13.39M	$ -41.86M	$ -12.10M	$ -15.09M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 80.74M	$ 91.42M	$ 102.04M	$ 65.50M	$ 78.31M
Total Assets	$ 83.05M	$ 95.86M	$ 106.53M	$ 70.35M	$ 82.17M
Total Debt	$ 369.00K	$ 474.00K	$ 577.00K	$ 678.00K	$ 774.00K
Net Debt	$ -80.37M	$ -90.94M	$ -101.46M	$ -64.82M	$ -77.53M
Total Liabilities	$ 11.04M	$ 11.80M	$ 78.22M	$ 11.49M	$ 12.09M
Stockholders Equity	$ 72.01M	$ 84.06M	$ 28.33M	$ 58.87M	$ 70.07M
Cash Flow	-
Free Cash Flow	$ -10.49M	$ -10.19M	$ -12.70M	$ -13.01M	$ -12.25M
Operating Cash Flow	$ -10.49M	$ -10.19M	$ -12.70M	$ -13.01M	$ -12.25M
Investing Cash Flow	-	$ -348.00K	$ 49.32M	-	-
Financing Cash Flow	$ -1.00K	-	$ -29.00K	-	$ 0.00

Currency in USD

Leap Therapeutics Earnings and Revenue History

Income Statement >

Leap Therapeutics Debt to Assets

Balance Sheet >

Leap Therapeutics Cash Flow

Cash Flow >

Leap Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing